Additionally, a recent study revealed diminished serum levels of TGF-β along with reduced PBMC mRNA expression of TGF-β and FOXP3 in RRMS patients compared to healthy controls [52]. The gene discussed is FOXP3; the disease is relapsing-remitting multiple sclerosis.